T1	Participants 90 94	acne
T2	Participants 417 519	This was an investigator-blinded, randomized, parallel group trial conducted at 3 centers in Thailand.
T3	Participants 520 701	Female subjects 18-45 years old were assigned to one or the other OCs and evaluated for efficacy and safety parameters at the baseline visit and after 1, 3 and 6 months of treatment
